Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMRS

Amyris (AMRS) Stock Price, News & Analysis

Amyris logo

About Amyris Stock (NASDAQ:AMRS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.05
$1.17
52-Week Range
N/A
Volume
46.75 million shs
Average Volume
12.59 million shs
Market Capitalization
$18.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Receive AMRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amyris and its competitors with MarketBeat's FREE daily newsletter.

AMRS Stock News Headlines

Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Amyris, Inc. (AMRS)
Amyris Receives Court Approval for Restructuring Plan
See More Headlines

AMRS Stock Analysis - Frequently Asked Questions

Amyris, Inc. (NASDAQ:AMRS) issued its earnings results on Monday, November, 8th. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.04. The company's quarterly revenue was up 39.7% on a year-over-year basis.
Read the conference call transcript
.

Shares of Amyris reverse split on the morning of Tuesday, June 6th 2017. The 1-15 reverse split was announced on Tuesday, June 6th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amyris investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), PayPal (PYPL), Tesla (TSLA) and

Company Calendar

Last Earnings
11/08/2021
Today
5/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Specialty Chemicals
Sub-Industry
Oil & Gas Refining & Marketing
Current Symbol
NASDAQ:AMRS
Employees
1,598
Year Founded
2003

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-528,510,000.00
Net Margins
-229.12%
Pretax Margin
-235.25%

Debt

Sales & Book Value

Annual Sales
$269.85 million
Price / Cash Flow
N/A
Book Value
($1.52) per share
Price / Book
N/A

Miscellaneous

Free Float
235,299,000
Market Cap
$18.47 million
Optionable
Optionable
Beta
1.19

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:AMRS) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners